Gastrointestinal Mesenchymal Neoplasms other than Gastrointestinal Stromal Tumors: Focusing on Their Molecular Aspects
2011

Gastrointestinal Mesenchymal Neoplasms: Molecular Insights

publication Evidence: moderate

Author Information

Author(s): Thomas P. Plesec

Primary Institution: Cleveland Clinic

Hypothesis

The review aims to highlight the molecular aspects of gastrointestinal mesenchymal tumors other than gastrointestinal stromal tumors (GISTs).

Conclusion

Molecular pathology plays a critical role in diagnosing and understanding the prognosis of rare gastrointestinal mesenchymal tumors.

Supporting Evidence

  • Gastrointestinal mesenchymal tumors are rare but can be diagnosed using molecular pathology.
  • Desmoid tumors often arise in young patients and can recur locally.
  • Inflammatory myofibroblastic tumors may have aggressive behavior and frequent recurrences.
  • Clear cell sarcomas are extremely rare in the GI tract and often present with metastasis.
  • Synovial sarcomas in the GI tract are uncommon and have specific genetic alterations.

Takeaway

This study talks about rare tumors in the stomach and intestines and how understanding their genes can help doctors treat them better.

Methodology

The review summarizes current knowledge on various gastrointestinal mesenchymal tumors and their molecular characteristics.

Limitations

The review is not exhaustive and focuses on selected tumors with well-characterized molecular pathology.

Digital Object Identifier (DOI)

10.4061/2011/952569

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication